mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.2 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.2 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.2 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |